ALLMedicine™ Abdominal Pain Center
Research & Reviews 13,665 results
https://doi.org/10.1111/apt.17399
Alimentary Pharmacology & Therapeutics; Regev S, Schwartz D et. al.
Feb 4th, 2023 - Chronic abdominal pain and fatigue are characteristics of Crohn's disease (CD) and contribute to functional impairments. To examine whether CD-tailored cognitive-behavioural and mindfulness intervention (COBMINDEX) is effective in reducing abdomin...
https://doi.org/10.1007/s11912-023-01370-z
Current Oncology Reports; Frenkel M, David A et. al.
Feb 4th, 2023 - Pancreatic cancer has high mortality and morbidity rates, associated with the issues of typically late diagnosis and the limited effectiveness of current treatments. Patients tend to experience multiple symptoms that can include anxiety, fear, dep...
https://emedicine.medscape.com/article/175909-overview
Feb 3rd, 2023 - Background Acute gastritis is a term that encompasses a broad spectrum of entities that induce inflammatory changes in the gastric mucosa. Several different etiologies share the same general clinical presentation; however, they differ in their uni...
http://emedicine.medscape.com/article/967822-overview
Feb 3rd, 2023 - Practice Essentials Pediatric pneumonia is responsible for the deaths of more than 800,000 young children worldwide each year, according to the United Nations Children's Fund (UNICEF). [1] These deaths occur almost exclusively in children with und...
http://emedicine.medscape.com/article/175909-overview
Feb 3rd, 2023 - Background Acute gastritis is a term that encompasses a broad spectrum of entities that induce inflammatory changes in the gastric mucosa. Several different etiologies share the same general clinical presentation; however, they differ in their uni...
Guidelines 21 results
https://doi.org/10.1053/j.gastro.2022.11.034
Gastroenterology Wang B, Bonkovsky HL et. al.
Jan 16th, 2023 - The acute hepatic porphyrias (AHP) are rare, inborn errors of heme-metabolism and include acute intermittent porphyria, hereditary coproporphyria, variegate porphyria, and porphyria due to severe deficiency of 5-aminolevulinic acid dehydratase. Ac...
https://doi.org/10.1016/j.jacr.2022.09.011
Journal of the American College of Radiology : JACR; , Kambadakone AR et. al.
Nov 28th, 2022 - This document focuses on imaging in the adult and pregnant populations with right lower quadrant (RLQ) abdominal pain, including patients with fever and leukocytosis. Appendicitis remains the most common surgical pathology responsible for RLQ abdo...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516804
World Journal of Emergency Surgery : WJES; De Simone B, Chouillard E et. al.
Sep 28th, 2022 - Patients presenting with acute abdominal pain that occurs after months or years following bariatric surgery may present for assessment and management in the local emergency units. Due to the large variety of surgical bariatric techniques, emergenc...
https://pubmed.ncbi.nlm.nih.gov/34068318/
Nutrients Rocco A, Compare D et. al.
May 13th, 2021 - Lactose intolerance (LI) is characterized by diarrhea, abdominal pain, or bloating occurring after lactose consumption in patients with lactose malabsorption. The National Institute of Health (NIH) proposed a double-blind placebo testing to identi...
https://doi.org/10.1016/j.jvs.2020.10.029
Journal of Vascular Surgery; Huber TS, Björck M et. al.
Nov 11th, 2020 - Chronic mesenteric ischemia (CMI) results from the inability to achieve adequate postprandial intestinal blood flow, usually from atherosclerotic occlusive disease at the origins of the mesenteric vessels. Patients typically present with postprand...
Drugs 700 results see all →
Clinicaltrials.gov 1,176 results
https://clinicaltrials.gov/ct2/show/NCT04605783
Feb 2nd, 2023 - Probiotics and passive immunoprophylaxis are classes of dietary supplements that are lawfully marketed in the US for maintenance of gut health (GH). This randomized, double-blind, clinical trial will evaluate one commercially available dietary sup...
https://clinicaltrials.gov/ct2/show/NCT05509725
Feb 2nd, 2023 - To monitor safety and to evaluate the efficacy of a probiotic formulation on severity of gastrointestinal symptoms (abdominal pain, abnormal defecation), anxiety, depression and quality of life in adult participants with IBS-D.
https://clinicaltrials.gov/ct2/show/NCT05342532
Feb 1st, 2023 - All patients, at least 18 years of age, with a chief complaint of dyspepsia and documented treatment-naïve HP infection diagnosed on UBT, esophagogastroduodenoscopy (EGD) with HP biopsy, or SAT were recruited for the study. Dyspepsia was defined a...
https://clinicaltrials.gov/ct2/show/NCT05281094
Feb 1st, 2023 - Noroviruses have emerged as the single most significant cause of gastroenteritis in both middle-high income countries and low resource settings worldwide. Those most at risk of severe illness include the very young, the elderly and immunocompromis...
https://clinicaltrials.gov/ct2/show/NCT05707429
Feb 1st, 2023 - Inflammatory Bowel Diseases (IBD), Crohn's disease (CD) and ulcerative colitis (UC), are characterized by a chronically relapsing course (1). IBD is likely to have a substantial impact on body image, intimacy and sexuality, Because of symptoms lik...
News 2,778 results
https://www.medpagetoday.com/nephrology/anemia/102928
Feb 2nd, 2023 - The FDA approved the first oral agent for chronic kidney disease (CKD)-related anemia for adults on dialysis, the agency announced late on Wednesday. Daprodustat (Jesduvroq) is a once-daily tablet specifically indicated for patients who have been ...
https://www.mdedge.com/internalmedicine/article/260911/gastroenterology/acute-hepatic-porphyrias-no-longer-rare-previously
Carolyn Crist
Jan 30th, 2023 - Although rare, acute hepatic porphyrias (AHPs) may be more common than previously thought, particularly among women between ages 15 and 50, according to a new clinical practice update from the American Gastroenterological Association. For acute at.
https://www.medpagetoday.com/hematologyoncology/breastcancer/102880
Jan 30th, 2023 - The FDA approved the selective estrogen receptor (ER) degrader elacestrant (Orserdu) for the treatment of postmenopausal women or adult men with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression...
https://www.mdedge.com/internalmedicine/article/260796/gastroenterology/proof-lacking-dual-targeted-therapy-benefit-ibd
Neil Osterweil
Jan 25th, 2023 - AURORA, COLO. – Only sparse evidence supports the use of dual-targeted therapy for patients with severe, refractory inflammatory bowel disease (IBD) -- and additional evidence will be hard to come by, according to a leading IBD researcher.
https://www.mdedge.com/psychiatry/article/260760/bipolar-disorder/medication-induced-rhabdomyolysis-patient-bipolar
Jayasudha Gude, MD, Viwek Bisen, DO et. al.
Jan 24th, 2023 - Editor’s note: Readers’ Forum is a department for correspondence from readers that is not in response to articles published in Current Psychiatry. All submissions to Readers’ Forum undergo peer review and are subject to editing for length and styl.